
Forest Laboratories will spend around $2.9 billion to purchase Aptalis, a privately-held US firm specialising in treatments for gastrointestinal disorders …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

